Showing results (151-160 of 1,072) with videos related to
Sort By:
Pageof 108
American Heart Journal|July 31, 2008
Clinical profile of prasugrel, a novel thienopyridineDominick J Angiolillo, Eric R Bates, Theodore A BassDiabetes & Vascular Disease Research|October 6, 2010
Antithrombotic therapy in patients with diabetes mellitus and coronary artery diseaseJosé Luis Ferreiro, Ángel R Cequier, Dominick J AngiolilloAdvances in Cardiology|August 22, 2012
PrasugrelAntonio Tello-Montoliu, Salvatore D Tomasello, Dominick J AngiolilloFuture Cardiology|September 26, 2015
Platelet thrombin receptor antagonism with vorapaxar: pharmacology and clinical trial developmentFrancesco Franchi, Fabiana Rollini, Yongwhi Park, et al.Expert Opinion on Drug Safety|December 19, 2015
A Safety Evaluation of Cangrelor in Patients Undergoing PCIFrancesco Franchi, Fabiana Rollini, Yongwhi Park, et al.Progress in Cardiovascular Diseases|August 17, 2015
Novel Antiplatelet Agents: The Current State and What Is Coming Down the PikeFrancesco Franchi, Fabiana Rollini, Yongwhi Park, et al.American Heart Journal|July 31, 2008
Current antiplatelet therapies: benefits and limitationsDominick J Angiolillo, Luis A Guzman, Theodore A BassEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|October 15, 2021
Reflections after TWILIGHT study: a new era in secondary prevention without aspirin?Giovanni Occhipinti, Davide CapodannoExpert Review of Cardiovascular Therapy|March 9, 2013
Dual antiplatelet therapy in patients with diabetes mellitus: special considerationsPiera Capranzano, Davide CapodannoEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|June 13, 2024
Factor XI inhibition in patients with acute coronary syndromeCarmelo Raffo, Davide CapodannoPageof 108